Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Silencing Stem Cell Factor Gene in Fibroblasts to Regulate Paracrine Factor Productions and Enhance c-Kit Expression in Melanocytes on Melanogenesis
Pin-Hui Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Stem cell factor is selectively secreted by arterial endothelial cells in bone marrow
Chunliang Xu et al.
NATURE COMMUNICATIONS (2018)
CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
Brittni M. Foster et al.
BIOMEDICINES (2018)
Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
Vijayalaxmi Gupta et al.
CANCERS (2018)
Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
Anna Pagotto et al.
CELL DEATH & DISEASE (2017)
Tumor-associated myeloid cells as guiding forces of cancer cell stemness
Antonio Sica et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells
Li Wang et al.
TUMOR BIOLOGY (2016)
Targeting the EGF/HER Ligand-Receptor System in Cancer
Azucena Esparis-Ogando et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes
Fabio Stagno et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages
Stefano Soldano et al.
PLOS ONE (2016)
Phenotypic, Functional, and Plasticity Features of Classical and Alternatively Activated Human Macrophages
Abdullah A. Tarique et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Maintenance of Clonogenic KIT+ Human Colon Tumor Cells Requires Secretion of Stem Cell Factor by Differentiated Tumor Cells
Szabolcs Fatrai et al.
GASTROENTEROLOGY (2015)
Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes
Young-Chan Kwon et al.
JOURNAL OF VIROLOGY (2015)
Prokineticin signaling is required for the maintenance of a de novo population of c-KIT+ cells to sustain neuroblastoma progression
S-T Lau et al.
ONCOGENE (2015)
High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t (8;21) Acute Myeloid Leukemia
Xiaoning Gao et al.
PLOS ONE (2015)
Modulation of c-kit expression in pancreatic adenocarcinoma: A novel stem cell marker responsible for the progression of the disease
Abraham Amsterdam et al.
ACTA HISTOCHEMICA (2014)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
Francesca Ricci et al.
CANCER RESEARCH (2014)
ABCB5 Maintains Melanoma-Initiating Cells through a Proinflammatory Cytokine Signaling Circuit
Brian J. Wilson et al.
CANCER RESEARCH (2014)
Organoid cultures for the analysis of cancer phenotypes
Norman Sachs et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2014)
C-KIT Signaling in Cancer Treatment
Karmen Stankov et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Yin and yang of tumor inflammation: How innate immune suppressors shape the tumor microenvironments
Masahisa Jinushi
INTERNATIONAL JOURNAL OF CANCER (2014)
Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts
V. Agnusdei et al.
LEUKEMIA (2014)
Regulation of the anti-tumour immune response by cancer-associated fibroblasts
James Harper et al.
SEMINARS IN CANCER BIOLOGY (2014)
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
Anna Pasto et al.
ONCOTARGET (2014)
Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Lipika Goyal et al.
CLINICAL CANCER RESEARCH (2013)
Therapeutic targeting of c-KIT in cancer
Leonie K. Ashman et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor
Aaron Rosenberg et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases
Jing Liang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2013)
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
William A. Flavahan et al.
NATURE NEUROSCIENCE (2013)
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling
W. K. Chau et al.
ONCOGENE (2013)
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
Helge Siemens et al.
ONCOTARGET (2013)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube
Ignacio Romero Noguera et al.
GYNECOLOGIC ONCOLOGY (2012)
Endothelial and perivascular cells maintain haematopoietic stem cells
Lei Ding et al.
NATURE (2012)
STEM CELL FACTOR RECEPTOR/c-KIT: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS
Johan Lennartsson et al.
PHYSIOLOGICAL REVIEWS (2012)
Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
Suling Liu et al.
CANCER RESEARCH (2011)
Regulation of Cancer Stem Cells by Cytokine Networks: Attacking Cancer's Inflammatory Roots
Hasan Korkaya et al.
CLINICAL CANCER RESEARCH (2011)
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
Lijing Luo et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Hasan Korkaya et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
Vera Levina et al.
CANCER RESEARCH (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
Salvatore Pece et al.
CELL (2010)
The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells
Angelo Cicalese et al.
CELL (2009)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF)
Zhi-Bo Han et al.
CARCINOGENESIS (2008)
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Russell J. Schilder et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation
Ana Preto et al.
VIRCHOWS ARCHIV (2007)
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: New molecules and patterns of gene expression
Fernando O. Martinez et al.
JOURNAL OF IMMUNOLOGY (2006)
The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells
Akira Yasuda et al.
MOLECULAR CANCER (2006)
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
A Sica et al.
EUROPEAN JOURNAL OF CANCER (2006)
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers
RL Coleman et al.
GYNECOLOGIC ONCOLOGY (2006)
The stem cell factor receptor/c-Kit as a drug target in cancer
J Lennartsson et al.
CURRENT CANCER DRUG TARGETS (2006)
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
SA Bapat et al.
CANCER RESEARCH (2005)
Progress and challenges in screening for early detection of ovarian cancer
IJ Jacobs et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Signal transduction via the stem cell factor receptor/c-Kit
L Rönnstrand
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Imatinib mesylate - In the treatment of gastrointestinal stromal tumours
KF Croom et al.
DRUGS (2003)
Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT)
M Miettinen et al.
MODERN PATHOLOGY (2000)
Share Paper
